Eric Venker $ROIV SEC Form 4 Insider Trading

Eric Venker has filed a total of 76 insider trades in $ROIV since 2021. Their most recent trade was a sale of 118,418 shares, made on Oct 17, 2025. Their largest trade was a sale of 683,818 shares, made on Sep 19, 2025. We estimate that they now own 9.8 million shares of $ROIV, worth an estimated $27.8 million.

Insider Trading at $ROIV

There have been a total of 185 insider trades reported at $ROIV since 2021, with 4.0 million shares purchased and 143.3 million shares sold. The most active insider traders in $ROIV stock have been Eric Venker, Rakhi Kumar, and Eric Venker. The most recent trade was a sale of 118,418 shares reported by Eric Venker (President & Immunovant CEO), made on Oct 17, 2025.

$ROIV Executives and Stock Owners with Insider Trades

• Eric Venker, President & COO

• Rakhi Kumar, Chief Accounting Officer

• Eric Venker, Chief Operating Officer

• Eric Venker, President & Immunovant CEO

• Matthew Gline, CEO

• Mayukh Sukhatme, Pres&Chief Investment Officer

• Richard Pulik, CFO

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.